Mometasone Furoate

  • Topical steroids

Mometasone Furoate Generic Name & Formulations

General Description

Mometasone furoate 0.1%; crm; oint.

Pharmacological Class


See Also

How Supplied

Crm, oint—contact supplier; Lotion—30mL, 60mL

Mometasone Furoate Indications


Corticosteroid-responsive dermatoses.

Mometasone Furoate Dosage and Administration

Adults and Children

<2yrs: not recommended. ≥2yrs: apply thin film once daily; max 3 weeks' therapy for children. Discontinue when control is achieved. Do not occlude.

Mometasone Furoate Contraindications

Not Applicable

Mometasone Furoate Boxed Warnings

Not Applicable

Mometasone Furoate Warnings/Precautions


Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Treat infection if present; discontinue if infection persists or worsens. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.

Mometasone Furoate Pharmacokinetics

See Literature

Mometasone Furoate Interactions

Mometasone Furoate Adverse Reactions

Adverse Reactions

Burning, pruritus, skin atrophy, tingling/stinging, furunculosis, acneiform reaction, folliculitis; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.

Mometasone Furoate Clinical Trials

See Literature

Mometasone Furoate Note


Formerly known under the brand name Elocon.

Mometasone Furoate Patient Counseling

See Literature